Neonates at Risk: Understanding the Impact of High-Risk Pregnancies on Neonatal Health
- PMID: 40572764
- PMCID: PMC12194930
- DOI: 10.3390/medicina61061077
Neonates at Risk: Understanding the Impact of High-Risk Pregnancies on Neonatal Health
Abstract
High-risk pregnancies (HRPs) constitute a significant global health issue due to their strong association with increased maternal and neonatal morbidity and mortality. Although pregnancy is generally characterized by positive expectations, the presence of maternal comorbidities, gestational complications, or adverse socioeconomic and environmental conditions can markedly elevate the probability of unfavorable outcomes. HRPs contribute disproportionately to complications such as preterm birth, fetal growth restriction, low birth weight, and congenital anomalies, which are key determinants of neonatal mortality and long-term developmental and health challenges. A broad spectrum of risk factors as well as insufficient prenatal care, underscores the complex nature of HRPs. These conditions necessitate a multidisciplinary management approach encompassing early risk identification, continuous monitoring, and individualized interventions. The neonatal prognosis in such contexts is strongly influenced by gestational age at delivery, birth weight, the standard of neonatal care, and the underlying etiological factors driving preterm or complicated deliveries. Preventive strategies including comprehensive prenatal screening, systematic antenatal follow-up, and timely referral to specialized perinatal care centers are essential for reducing the burden of HRPs. Furthermore, addressing social determinants of health-such as low socioeconomic status and limited access to healthcare-is critical for optimizing maternal and neonatal outcomes. This review consolidates current evidence on the epidemiology, etiological factors, and clinical implications of high-risk pregnancies, emphasizing the necessity of an integrative, preventive, and multidisciplinary framework to mitigate adverse neonatal outcomes and improve long-term health trajectories.
Keywords: SARS-CoV-2 infection; congenital infections; fetal growth restriction; gestational diabetes mellitus; high-risk pregnancies; neonates; preeclampsia; prematurity; substance use.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012910. doi: 10.1002/14651858.CD012910. Cochrane Database Syst Rev. 2018. PMID: 29303230 Free PMC article.
-
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Dec 25;12:CD004454. doi: 10.1002/14651858.CD004454.pub4. PMID: 28321847 Free PMC article. Updated.
-
Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4. Cochrane Database Syst Rev. 2021. PMID: 34935127 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Maternal and neonatal outcomes of elective induction of labor.Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Evid Rep Technol Assess (Full Rep). 2009. PMID: 19408970 Free PMC article.
References
-
- Alkema L., Chou D., Hogan D., Zhang S., Moller A.B., Gemmill A., Fat D.M., Boerma T., Temmerman M., Mathers C., et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: A systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016;387:462–474. doi: 10.1016/S0140-6736(15)00838-7. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous